About: VOLT-02

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet.

Property	Value
dbo:abstract	VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet. (en)
dbo:class	dbr:Progestogen dbr:Neurosteroid
dbo:wikiPageExternalLink	https://adisinsight.springer.com/drugs/800041522 http://www.levoltapharma.com/pipeline/
dbo:wikiPageID	57017072 (xsd:integer)
dbo:wikiPageLength	2757 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1042306239 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Progesterone_(medication) dbr:Menstrual_disorder dbr:Progestogen dbr:List_of_investigational_sex-hormonal_agents dbr:List_of_neurosteroids dbr:List_of_progestogen_esters dbc:Experimental_drugs dbc:Neurosteroids dbc:Pregnanes dbc:Progestogens dbr:Chemical_structure dbr:Clinical_trial dbr:Traumatic_brain_injury dbc:Neuroprotective_agents dbc:Drugs_with_undisclosed_chemical_structures dbr:Neurosteroid dbr:Phases_of_clinical_research dbr:Water-soluble dbr:Conjugate_(biochemistry) dbr:Gynecological_disorder
dbp:class	dbr:Progestogen dbr:Neurosteroid
dbp:synonyms	Progesterone conjugate (en)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Nervous-system-drug-stub dbt:Progesterone_receptor_modulators dbt:Reflist dbt:Steroid-stub
dcterms:subject	dbc:Experimental_drugs dbc:Neurosteroids dbc:Pregnanes dbc:Progestogens dbc:Neuroprotective_agents dbc:Drugs_with_undisclosed_chemical_structures
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug
rdfs:comment	VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders. As of March 2017, it is in phase II clinical trials for these indications. The chemical structure of VOLT-02 does not appear to have been released yet. (en)
rdfs:label	VOLT-02 (en)
owl:sameAs	wikidata:VOLT-02 https://global.dbpedia.org/id/6AL8L
prov:wasDerivedFrom	wikipedia-en:VOLT-02?oldid=1042306239&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:VOLT-02
is dbo:wikiPageRedirects of	dbr:VOLT02 dbr:VOLT_02
is dbo:wikiPageWikiLink of	dbr:Progesterone_(medication) dbr:Progestogen_ester dbr:List_of_investigational_sex-hormonal_agents dbr:List_of_progestogen_esters dbr:VOLT02 dbr:VOLT_02
is foaf:primaryTopic of	wikipedia-en:VOLT-02